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Summary: Enzyme release was studied in various tissues in intact animals or by means of tissue slices, organ
perfusion or isolated and cultured cells. The factors that determine the extent and the time course of the
leakage were studied extensively with several liver enzymes. It was found that the molecular properties of
the enzymes, their topology within the organ, their intracellular localisation, their inducibility on the one
hand, the nutritional and energetic state of the organ, and the respective protein turnover on the other, and
finally, the type of the organ lesion all contribute to the different release patterns, which are known from
experimental studies, and which are utilized for the diagnosis of diseases.
While these preconditions of enzyme release are fairly well understood, the nature of the membrane alterations
and the mechanisms of detachment and transport of the enzyme proteins are less clear. Different models
have been proposed, which may not exclude each other. Alterations of the cytoskeleton and the lipid
composition of the plasma membranes are closely linked to ion imbalance, which is, in turn, dependent on
the energy state of the individual cellular compartments.
Introduction
Our interest in the phenomenon of cell enzyme release
arose soon after we had begun in 1956 to determine
enzyme activities in liver biopsies and sera of our
patients with liver diseases. The inconsistency be^
tween the prevailing dpctrine that the cell enzymes in
plasma would originate from cell necrosis, and our
own experience, shown in figüre l (l a), namely that
the modifications of the enzyme activities in serum
reflect neither directly nor reciprocaüy the enzyme
activities and their respective change? in the liver,
induced us to reconsider (l b) and to actively mvesti-
gäte the problem (2—5).
For the purposes of studying enzyme release into
plasma without the effects of distribution and elimin-
ation (6, 7), patients and whole experimental animals
were too complicated äs experimental Systems. Sim-
pler Systems were therefore designed, from perfused
organs to purely synthetic membranes (tab. 1). The
more artificial the Systems were, the more susceptible
they became to slight variations in methodology, and
this may be one reason why different answers are
frequeiitly given in the literature to the apparently
simple questions:
1. Why do cells lose their enzymes, which they need,
and which have no extracellular functions? Is the
conservation of the enzyme equipment of cells
only a question of energy?
2. What modifies the extent of enzyme losses, so that
various, sometimes highly characteristic enzyme
patterns appear in plasma, which are different
from the enzyme patterns of the organs of origin?
3. How do cellular enzymes pass into the extracellu-
lar space?
Which structures and processes are involved —
actively or passively?
The attempt to answer these questions will Start —
äs far äs possible — from own investigations, accord-
ing to the nascent tradition of the Szäsz Lecture.
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Fig. 1. Enzyme activities in normal human liver and serum (C±]) and in human liver and serum in acute viral hepatitis (j
Because of limited space the enzymes were abbreviated äs follows:
SDH = sorbitol dehydrogenase, ,-iditol dehydrogenase (EC 1.1.1.14);
GAPDH = glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12);
LDH = lactate dehydrogenase (EC 1.1.1.27);
ICDH = isocitrate dehydrogenase (EC 1.1.1.42);
MDH = malate dehydrogenase (EC 1.1.1.37);
GIDH = glutamate dehydrogenase (EC 1.4.1.3);
ASAT = aspartate aminotransferase (EC 2.6.1.1);
ALAT = alanine aminotransferase (EC 2.6.1.2);
HK = hexokinase (EC 2.7.1.1);
PFA = fructose-bisphosphate aldolase (EC 4.1.2.13) (F-l-P);
G6PDH = glucose-6-phosphate dehydrogenase (EC 1.1.1.49);
PGDH = phosphogluconate dehydrogenase (EC 1.1.1.44);
ALD = fructose-bisphosphate aldolase = (EC 4.1.2.13) (F-1,6-P2);
GDH = glycerol-3-phosphate dehydrogenase (EC 1.1.1.8);
ENO = enolase(EC 4.2.1.11);
PK = pyruvate kinase (EC 2.7.1.40);
ADH = alcohol dehydrogenase (EC 1.1.1.1)
n = 7 — 24; Mean values;
from I.e. (la), modified.
Tab. 1. Systems used in the study of enzyme release.
1. Patients or healthy volunteers
2. Animals, plants, microorganisms
3. Perfused organs
4. Isolated organs or tissue slices
5. Isolated or cultured cells
6. Isolated cell organelles
7. Artificial membranes or vesicles
Various models for the study of enzyme release have
been designed on the basis of the respective cöncepts
of cell metabolism, äs well in analogy with clirücal
Problems (tab. 2). Thus the inVestigation of the effects
of anoxia have likewise deepened tbe understäriding
öf myocärdial infarctiön, shock and other states of
circulatory failure and have led to new general in-
sights into enzyme release. ,
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Tab. 2. Models used in the study of enzyme release.
1. Modification of oxygen supply
a) Hypoxia and anoxia
b) Low-flow and ischaemia
c) *The oxygen paradox"
2. Modification of Substrate supply
a) Fasting
b) Carbohydrate depletion
c) Protein imbalance
3. Modification of intracellular metabolism
a) Inhibition of glycolysis
b) Inhibition of oxidation
c) Uncoupling of oxidative phosphorylation
d) Inhibition of protein synthesis
e) Enzyme induction
4. Modification of cellular structures
a) Detergent action
b) Impairraent of the cytoskeleton
c) Lipid peroxidation
d) Electrolyte imbalance
Modification of oxygen supply
Figure 2 shows experiments with the isolated haemo-
globin-free perfused rat liver (5, 7, 8). The effects of
three different forms of oxygen deprivation on en-
zyme release are compared with the course of norm-
oxic liver perfusion at 23 °C (9). As examples, the
activities of cytosolic, periportally prevailing alanine
aminotransferase, öf cytosolic äs well äs mitochon-
drial, evenly distributed aspartate aminotransferase,
and of purely mitochondrial, perivenously predomi-
nant glutamate dehydrogenase are shown in the per-
fusion medium. As metabolic reference data the oxy-
gen consumption of the liver and the lactate/pyruvate
ratio in the medium are given.
Among the curves in figure 2 the temperature-in-
duced relative hypoxia (H) is conspicuous. Although
oxygen consumption at 37 °C is more than twice
than at 23 °C, it is insußicient to meet the higher
requirements of the accelerated metabolism (9). After
the first hour, the lactate/pyrüvate ratio mcreases
steadily and simultaneously with the elevation of as-
partate aminotransferase, before the increased release
of alanine aminotran$ferase and after the early leak-
age of glutamate dehydrogenase. The temporal order
is due to the intralobular distribution of the three
enzymes and the mainly perivenous site of action of
the hypoxie cell damage.
This deduction is suppprted by the reäctions öf the
three enzymes during and after the one-hour anoxia
in the course of the perfusion (A): Only glutamate
dehydrogenase shows an immediate, higher release
rate, while the aspartate aminotransferase release rate
is increased only after re-oxygenation, when oxygen
consumption and the lactate/pyruvate ratio have al-
ready returned to the initial values. Finally, the slope
of alanine aminotransferase elevation does not differ
significantly from that of the controls (C).
In the third example, hypothermic perfusion after 20
minutes of warm ischaemia (I), the first activities
of the cytosolic enzymes are elevated, for obvious
reasons. So is the initial oxygen consumption, which
brings the lactate/pyruvate ratio promptly to control
levels, and which stays in the control ränge after the
first hour. The further slope of the release rates of
the enzymes is then only negligibly steeper than in
controls.
The higher sensitivity of the totally or partially cyto-
solic enzymes, compared with the mitochondrial
ones, can be easily recognized from the different
scales, which are required in figure 2 for the demon-
stration of their release rates: referred to the respec-
tive activity in the liver, nearly 100 times more alanine
aminotransferase %and about 20 times more aspartate
aminotransferase are released äs compared with glu-
tamate dehydrogenase.
Hitherto, the experimental results can be summarized
äs follows:
1. Hypoxia, anoxia and ischaemia lead to release of
cellular enzymes.
2. The extent and the course of their elevation in the
extracellular space depend on the concentration
gradient, the iritralobular distribution and the in-
tracellular localization of the enzymes; moreover,
they also depend on the extent and duration of
lack of oxygen, the perfusion and the actual meta-
bolic activity of the liver.
This last factor becomes particularly clear on figure 3
which shows the deleterious effects of higher tempera-
ture after hyperthermia on the leakage into the perfu-
sion medium of a number of cellular enzymes: after
the delayed increase of enzyme activities during the
three houfs at 20 °C, rewärrning leads to a steep
elevation, which totally cancels the economizing
effects of hypothermia (2).
These experiments do not show whether the rise in
temperature affects enzyme release only by widening
the gap between energy requirement and oxygen sup-
ply, or whether the acceleration of diffusion and
transport also leads to accelerated physical loss of
enzymes. Investigations with isolated skeletal muscles
häve shown such a dependency of enzyme release on
geometry and diffusion velocity (10).
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Fig. 2. Release of enzymes from the isolated haemoglobin-free perfused rat liver into the mediurn, given äs fractiön of their
activity in the liver.
I: Ischaemia, 20 min before perfusion at 23 °C
n = 4
A: Anoxia, l hoür after l hour normoxia; 2 hours reoxygenation at 23 °C
n = 4
argon instead of oxygen
H: Hypoxia (relative) 4 hours perfusion at 37 °C
n = 2
C: Control, 4 hours normoxic perfusion at 23 °C
n = 10
Bottom: O2 consumption of liver
Lactate/pyruvate quotient in the perfusate. Mean values;
from I.e. (5), modified.
Another phenomenon, the so-called oxygen paradox,
is barely recognizable from our own experiments. A
significant elevation of release rates with re-oxygena-
tion after anoxia was demonstrated only fpr aspartate
aminotransferase. One reason for this may be that
the constancy of flow masked the change from anoxia
to normoxia in our procedure, äs in studies with
cultured cells, which led to similar results (11).
In experimental designs that produce hypoxia or
anoxia by low-flow or no-flow, the enhancement of
metabolism by the restoratioii of oxygen supply may'
be superimposed by the effect of wash-out phenqm-
ena (12—15), The same is true with re-perfusion
after ischaemia (16 — 18), or when coxnparing enzyme
leakage from exercising heart or skeletal muscle with
that of a resting organ, or an organ kept at constant
volume (13, 19, 20).
Figure 4 from a paper of Lemasters et al. shows
the oxygen paradox, exemplified by the loss of total
protein and lactate dehydrogenase from the perfused
liver, which occurs after the tennination öf the hyp-
oxic low-flow periöd, and is dependent on its duration
(15), ;·
j. Clin. Chem. Clin. Biochem. / VoL 25,1987 / No. 9
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Fig. 3. Hb-free perfused rat liver; Release of enzymes into the perfusion medium during 4 h at 37 °C and during 3 h at 20 °C
followedby 2 hat 37 °C.
Abbreviations used for enzymes see fig. l, in addition:
PGK = phosphoglycerate kinase (EC 2.7.2.3);
n = 3 — 17; Mean values;
from 1. c. (2), modified.
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Modification of Substrate supply
It is to be expected that lack of Substrate, like lack
of oxygen, also diminishes the energy-yield of cells
and leads to increased membrane permeability.
Figure 5 shows again the release rates of alanine
aminotransferase, aspartate aminotransferase and
ghitamate dehydrogenase from the isolated, perfused
rat liver. The reference data are the concentrations
in the medium of glucose and pyruvate, the glycogen
concentration in the liver before, and its decrease
after, perfusion, and the ATP and ADP concentra-
tions in the liver at the end of perfusion (5, 7). These
Parameters are compared under different conditions
of endogenous and exogenous supply of Substrates
at 23 °C. The fed (F) animals correspond to the
normoxic control group of the hypoxia experiments.
S denotes rats after 48 hours of fasting. In the FG
and SG groups glucose (otherwise 5.5 mmol/1) was
omitted from the perfusion medium.
Fig. 4. tactate dehydrogenase and protein release into the ef-
fixient perfusate after reoxygenation of hypoxic livers.
JStriped bars indicate periods of low flow;
jfrom I.e. (15), modified.
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Fig. 5. Release of enzymes from the isolated, haemoglobin-free perfused rat liver into the medium, given s fr ction of their
activity in the liver.
F: Fed rats (controls), perfusion with 5 mmol/1 glucose
n = 10
FG: Fed rats — glucose free perfusion
n = 3
S: Starved rats (48 h), perfusion with 5 mmol/1 glucose
n = 6
SG: Starved rats — glucose free perfusion
n = 3
Bottom: Metabolite concentrations in the perf sate (left);
in the liver (right)
b: before perfusion
a: after perfusion
T: ATP after perfusion
D: ADP after perfusion
Mean values;
from 1. c. (5), modified.
The great significance of a sufficient supply of sub- ferase and glutamate dehydrogenase 5-fold, com-
strates for glycolysis is evident. When a liver has pared with a well-nourished liver. The soufce of the
exhausted its glycogen Stores and no exoge ous glu- Substrates for glyeolysis ppeats of no consequence;
cose is available, the loss of alanine aminotransferase the increased release rates of the enzymes differ only
increases 20-fold, and that of aspartate aminotrans- c insignificantly in response to4 glycogen or glucose
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 9
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deprivation. The glucose-free perfused livers, how-
ever, consume more glycogen than the livers supplied
with glucose. The former use their glycogen to build
up a "normal" glucose level in the perfusion medium.
As expected, livers of fasted animals with very low
glycogen levels are unsuccessf l in raising the glucose
level of the perfusate.
The results of these and similar experiments indicate
that enzyme release due to cellular injury, caused e. g.
by hypoxia or by toxins, is modified by the nutritional
state of the liver, particularly the availability of fuel
for glycolysis, the nature of which is of no signifi-
cance.
The relationship between the integrity of cells and
their respective levels of glycogen and ATP has been
well known for decades. This is also true with respect
to organs other than liver (21—23), which has been
the subject of repeated studies. Figureo gives an
example of such correlations between the release of
malate dehydrogenase, the production of lactate and
the ATP concentrations in cultured cardiomyocytes
(24a). In 1984, Piper et al., using their own different
model System, reported results similar to those ob-
tained with perfused liver. They also found no oxygen
paradox, only one third of the previous enzyme leak-
age, when glucose was added to the medium, and less
lactate production after 60 minutes of incubation.
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Fig. 6. Energy metabolism and enzyme release of cultured adult
rat cardiocytes.
Correlation between lactate production rate (expressed
s fraction of the 15 min value: 1.2 μιηοΐ/gxmin) and
ATP content (f ll circles); y = ll.Sx + 28.2; r = 0.98;
P < 0.001.
Correlation between released malate dehydiogenase ac-
tivity (expressed s fraqtion of total cell lar activity of
contrpl) and ATP content (open circles); y = -1.5x
-h 10.3; r « -0.98; P < 0.0001 (mean values, n = 5);
from I.e. (24b), modified.
They attribute the gradual impairment of glycolysis,
which initially yielded 90% of total synthesized ATP,
to several factors: Inhibition of glyceraldehyde phos-
phate dehydrogenase, lack of co-substrate for the
fructose-6-phosphokinase reaction, and imbalance of
the ion composition. They conclude from the litera-
ture (16, 25, 26), and from their own fmdings in
the experiments with cardiomyocytes, that the cell
damage is reversible above an ATP concentration of
2 μηιοΐ/g, despite considerable enzyme losses, which
depend on the intracellular localization of the respec-
tive enzymes and in general on the preceding or actual
metabolic activity of the cells (11). These conclusions
correspond to our former deductions from our find-
ings in the perfused liver.
Inhibition of metabolism
Since the early investigations, individual inhibitors of
metabolism with known site of impact have been
used with the aim of localizing the state or process,
which initiates the release of cellular enzymes, and to
learn the sequence of events, including "the point of
no return" with respect to cell damage (2, 3, 22, 27).
In figure 7, the effects of iodoacetate (IAA), which
inhibits glycolysis, and of potassium cyanide (KCN)
which blocks cell respiration, on the isolated perfused
rat liver are demonstrated, again exemplified by the
release rates of the same three enzymes s in the
former similar figures.
The reference data include lactate and pyruvate con-
centration in the medium and the distribution of the
cytosolic and mitochondrial isoenzymes of aspartate
aminotransferase and malate dehydrogenase, which
link the two compartments via the aspartate malate
shuttle, in the liver (28 a).
Considering only the loss of enzymes, the toxic effect
of iodoacetate is much more severe than the KCN-
induced liver damage. In the latter the activity of
liver glycolytic enzymes increases by 80%, and 10
times s much lactate is produced and released in the
perfusion medium. By this enhancement of glycolysis
the liver cells are evidently able to maintain a sufli-
ciently high level of intermediates, and to adequately
regulate metabolism, so that a marked increase in
enzyme leakage is prevented. In contrast, when gly-
colysis is inhibited, the enzyme loss is so great that
the concentration gradients between the cytosolic and
the extracellular space fall below two.
Similar observations have been made by others. For
example, some findings with the Langendorff-
perfused rat heart, s reported 1983 by Higgins &
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 9
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Fig. 7. Release of enzymes from the isolated, haemoglobin-free perfused rat liver into the niedium, given äs ffaction of their
activity in the liver (fasted rats, 37 °C; mean vaiues)
C: Controls
n = 10
IAA: Monoiodoacetate
— l mmol/1 perfusion medium
n = 3
KCN: Potassium cyanide
— l mmol/1 perfusion medium
n = 5
Bottom: Metabolite concentrations in the perfusate
Isoenzymes in the liver after perfusion, given äs fraction of activity in the liver before perfusion. -
c —: cytosolic
m —: mitochondrial
ASAT = aspartate aminotransferase
^^KL = nialate dehydrogenase. In vitro Inhibition of aminötfansferases is corrected by calculation^
from 1. c. (28 a), modified.
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Baylay (22) are shown in figure 8. During perfusion
with a medium containing 0.2 mmol/1 iodoacetate
they observed a considerable release of laclate dehy-
drogenase äs soon äs lactate production ceased, while,
with l mmol/1 KCN in the perfusion medium, gly-
colysis was enhanced and the loss of lactate dehydro-
genase was only slight. In both cases, the decrease of
ATP was very similar. However, the concentration of
total adenine nucleotides in the tissue feil by 50% in
iodoacetate intoxication, while it remained constant
during the application of KCN.
It can be concluded from these and similar experi-
ments that enhanced glycolysis yields sufficient en-
ergy, despite inhibited respiration or oxidative phos-
phorylation, to lessen or even prevent increased leak-
age of constitutive enzymes from liver or muscle cells.
The reverse Situation, i. e. Inhibition of glycolysis with
no Inhibition of respiration, does not have the same
effect.
/rrn
i
0 30 60 90 120
Time of perfusion [min]
Fig. 8. Effect of l mmol/1 cyanide (·), 0.1 mmol/1 iodoacetate
(p) or no additions (A) on:
a) release of lactate dehydrogenase; b) perfüsate glucose
concentration·; c) perfüsate lactate concentration
in isolated rat hearts during 150 min perfusion.
Data are presented äs mean ± S. E. for four hearts;
from L c. (22), modified.
These observations, which have been confirmed by
other investigators, led to two hypotheses: firstly,
that an adequate pool of adenine nucleotides, even
exogenously substituted, enhances the integrity of
cells and prolongs their survival in adverse conditions
(25). Some doubt is cast on the causative role of total
adenine nucleotide concentration in cell damage and
preservation by the temporal sequence of the meta-
bolic events (22).
The other concept states that glycolytically produced
ATP, with or without actual compartmentation,
would play a special role in the maintenance of the
cytomembranes and the cytoskeleton (22, 23, 28 b).
Modification of protein synthesis
Besides the quantitative energy-related prerequisites
of Substrate supplementation, there are also qualita-
tive aspects. Not only the amount, but also the com-
position of the nutrients affect enzyme release by
modifying the susceptibility of cells via altered meta-
bolic equilibria (12, 29). Clinical observations äs well
äs experimental findings suggested that the direct
effects of protein synthesis in the liver on the release
of constitutive cell enzymes in acute injury should be
studied after an enhancement of the former by a
protein-rich diet. As noxious agent, galactosamine
was chosen, because its effects are virtually not af-
fected by induction of the biotransformation System
(30).
The upper part of figure 9 shows the three exemplary
enzymes in the plasma of rats, which received a non-
lethal dose of galactosamine. The toxin was applied
to the aiiimals of the P group on the sixth day of an
extremely protein-rich diet, and the animals of the N
group were fed a balanced Standard diet. Before.th^.
intoxication, the enzyme activities in plasma were
identical in both collectives. After galactosamine,
however, the peak values of alanine aminotransferase
showed a 6-fold increase, those of aspartate amino-
transferase increased neärly 4-fold, and those of glu-
tamate dehydrogenase more than 8-fold in the plasma
of the protein-rich fed rats, compared with the rats
on the Standard diet.
In the lower part of figure 9, the corresponding cata-
lytic activities in the liver are shown. The increased
enzyme synthesis is evident from the significantly
higher catalytic concentrations of the aminotransfer-
ases before galactosamine, while, äs expected, the
effect on glutamate dehydrogenase is less dramatic.
After the application of galactosamine, these different
enzyme activities decreased by 40-50% in the livers
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 9
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Fig. 9. Galactosamine-induced liver injury: Course of enzyme activities in plasma (top) and liver (bottom) of rats (£ ± SEM,
n = 30), fed a protein-rich (92% protein, o —o) or a Standard diet (20% protein, o — — — o)
l = 0.4 g galactosamine HC1 per kg body weight i. p.;
from 1. c. (30), modified.
of the N rats, and by only 10—15% in the livers of
the P animals. Moreover, in the latter group restora-
tion of the tissue activity occurs in excess, äs soon äs
the leakage into the extracellular space has ceased.
The question arises äs to whether the higher concen-
tration gradient alone accounts for the fact that the
increase in the plasma is so much greater in the
protein-rich nourished animals. Figure 10 shows the
release rates of the enzymes for the two dietary
groups. It is evident that the different concentration
gradients do not suffice äs an explanation. Even on
the basis of the higher activities in liver tissue, the
catalytic concentrations of the aminotransferases in
P rats are nearly twice äs high äs those in the N
rats, while ghitamate dehydrogenase shows a 6-fold
increase. The release rates are higher in themselves.
Morphologically there is no indication of a less severe
cell damage in the P rats: the histology of the respec-
tive livers differed in small details, but there was no
difference in the extent or duration of cellülar injury
(30).
The positive correlation between enzyme synthesis
and enzyme levels in plasma for a particular cell
injury may provide a basis for some observations
in clinical hepätology, which are otherwise hard to
explain, e.g. the pre-final fall of aminotransferases iii
plasma in fatal liver insufficiency, or the mitigated
courses of enzymes in serum in immünocompromised
or immunosuppressed patients, despite their progres-
sive inflammatory liver diseäses.
Others have established a positive correlation be-
tween enzyme synthesis and enzyme release by the
opposite approach, i. e. by the use öf inhibitors of
protein synthesis, such äs eycloheximide (12, 31 — 33).
Pappas (33), from bis findings with acüte earbon
tetrachloride pöisonhig, comes to the rather far re-
aching conclusion that the leakage of cell enzymes
could be äs much an indication of cellülar regener-
ation äs a sign of cell damage. However, he does
not discuss the problem of the suppressiöii of the
biotransformation of cafbon tetrachioride by eyclo-
heximide.
Nevertheless, äs early äs 1962, McLean (34) reported
that düring refeeding of mal· and undernourished
Jamaican children with a high-protein diet, sudden
transient elevations of alanine aniinotransferase and
isocitrate dehydrogenase occurred in plasma with no
indication of liver disorders or t£e slightest distur-
bance of the children's well-being. Thereupon, he
formed the hypothesis that in the course of a precipi-
tated reparation of enzyme losses with plenty of sub-
strate supply, dernovo-syntfeesis of enzymes may
J. CUn. Chem. Clin. Biochem. / Vol. 25,1987 / No. 9
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Standard diet.
For explanations see fig. 9;
from 1. c. (30), modified.
exceed the production of stabilizing cellular struc-
tures, so that the new constitutive enzymes wpuld be
lost instead of being transferred to and fixed at their
respective sites of actiöii.
Experimental coüfirmätion of this possibility is, how-
ever, lacking. Rather, there are cpntradictpry find-
ings, e. g. the proof that in cultured hepatocytes in the
presence of galäctosamine üiewly synthesized lactate
dehydrogenase dpes not leak intP the surroundihg
medium without having mixed with the previously
existing pool of lactate dehydrögenase (35). However,
in these experiments, enzyme synthesis was inhibited,
not enhanced. Moreover, lactate dehydrogenase, a
cytosolic protein, which bears no signal peptide and
does not require much vectorial processing, may not
be repräsentative of other enzymes, which are synthe-
sized by free ribösömes, but transported to other
compartinents for metabplic action. The import into
nütochondria, e. g., through the inner membrane, de-
pends pn the ATP concentration in the mitochondrial
inatrix and can be prevented by Inhibition of respir-
ation or oxidative phpsphorylation (36).
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Nevertheless, whether enzymes are produced by pro-
cessing of precursor peptides or not, the molecules
found in the plasma correspond to the mature "work-
ing*' form or an even later molecular modification
(37, 38).
Modification of membrane structure
The still widespread conviction that cellular enzymes
in the plasma originate from cell necrosis is sustained
by the difficulty in imaging how these macromolecu-
les apparently transgress the cell membrane äs easily
or even more easily than much smaller molecules, a
phenomenon, on which the diagnostic sensitivity of
enzyme determination in serum is based.
Wilbrandt published 1941 one of the oldest reflections
on the subject. He considered the colloid-osmotic
swelling with stretched and finally torn membranes,
due to the failure of ion pumps, to be the main reason
for a passively increased cell permeability (39).
%
In the fifties Zierler explained the enzyme efflux from
the working or injured muscle by the enhancement
or the disorder of the continuous oscillations of the
plasma membranes, which leads to the irregulär oc-
currence of more or less wide gaps (40). Neither
hypothesis is disproved, and they even seem more
probable in the light of recent studies on pathological
pores in plasma membranes, e. g. those caused by
bacterial exotoxins. However, both theories assign to
the damaged plasma membrane the properties of a
molecular sieve, and this is not in agreement with all
findings in the various pathological conditions.
In the early seventies, the development of electron
microscopy and an increased ünderstanding of the
structure of cytomembranes and the cytoskeleton
gave rise to another proposed mechanism, i. e. dis-
orders of the membrane by cross linking, detachment
or depolymerisation of the cytoskeletal actin fila-
ments. This was first described on isolated hepatocy-
tes in phalloidin poisoning (41), and later recognized
äs a fairly common and noü-specific phenomenon
(15, 42—46). It is illustrated in figure 11: in addition
to a normal hepatocyte covered evenly with small
microvilli, the figure shows a cell damaged by ethanol,
and another injured by phalloidin, both of which
show severe alterations of their plasma membranes
(46).
Destruction and cross-linking of actin filaments both
labilize the plasma membrane, which forms protru-
sions in isolated cells, according to the pressure gra-
dient. These so-called blebs can separate from the cell.
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Fig. 11. Scanning electron micrographs of isolated hepatocytes.
A: Typical hepatocyte from control rat showing abundant microvilli uniformly covering the cell surface.
B: Hepatocyte from ethanol-fed rat showing the appearance of blebs on the cell surface with a diminished number of
microvilli.
C: Blebbing of the plasma membrane in hepatocyte treated with phalloidin.
(A) 3000; (B) 2800; (C) 2950.
from L c. (46).
In whole tissue they are represented by membrane pits
and vesicles, which can also be shed or emptied into
the extracellular space (38). "Blebbing", "vesicle
shedding", "apoptosis" and "zeiosis" are often used
synonymously, but it is not always certain that they
describe the same thing. Marked differences exist e. g.
in the size of the vesicles. Moreover, some aüthöfs
never find mitochondria within the blebs (47, 48).
Thus, these investigators consider blebbirig to be the
reason for the lack of negative correlation between
the molecular mass of the enzymes and their release
rates in all pathological conditions (3, 49, 50), arid
for the low release rates of the mitochondrial enzymes
and isoenzymes compared with those of cytosolic
enzymes (48, 49).
Others, however, have demonstrated the occurrence
of mitochondria in the blebs (11). The composition
of the protrusions differs also in other respects: in
part they appear to consist virtually of membrane
fragments with the respective membrane-bound en-
zymes (42, 51), in part they contain cytosolic enzymes
enveloped by one of the two lipid-layers of the plasma
membrane (52), and finally no plasma membrane-
like envelope the various mostly cytosolic enzymes
can be detected (15).
There are areas of agreement, e. g. on the reversibility
of vesiculation — at least up to a certain size of the
vesicles — analogous to the reversibility of general
cell swelling. It follows that the enzymes, which are
thereby released, come from living and, äs a rule,
surviving cells.
Some authors even consider blebbing to be a protec-
tive mechanism, which prolongs or guarantees the
survival of the cells. The local extrusion of cellular
material diminishes the pressure within the cells and
the cellulaf Volume, and by sacrificing a portion, the
whole is saved (47, 53).
Figure 12 shows experiments with rat skeletal muscle,
which make it plausible that the release of cytosolic
enzymes, e. g. lactate dehydrogenase Starts immedi-
ately when, by blebbing, the volume of the cells
swollen in hypotonic medium is suddenly reduced.
This is, of course, a regulated process, depending oii
ATP from oxidative phosphorylation, which rather
contradicts the special role which has been assigned
to glycolytically produced ATP. Namely, when 2,4-
dinitrophenol is added, the swelling increases steadily,
but the enzyme leakage is only one half (47).
The temperature-dependence of the contf action-me-
diated or at least contraction-associated enzyme
losses from heart and skeletal muscles, which are
caused by anoxia, 2,4^dinitrophenol or caffeine dur-
ing calcium-free perfusion, or by the calcium para-
dox, can be attributed to differences in metabolic
activity äs well äs to differences in the velocity of in-
and efflux of ions, which alter the properties of the
membranes (19, 41, 5l, 54, 55). Both causes are
interreläted by direct effects of calcium.
Role of calcium homoeostasis
Ca2+ ions bind to anionic groups of phospholipids
and glycolipids in the mernbranes and thereby reduce
membrane fluidity. TableS show^ that addition of
calcium to calcium-free incubated hepatocyte plasma
membranes increases the fractions of free fatty acids
and lysolecithin, but diminishes, that of phosphatidyl-
ethanolamine (56). The kinetics and character of the
J. Clin. Chem. CUn, Biochem, / Vol. 25,1987 / No. 9
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Fig. 12 a. Swelling of skeletal muscle under nonpoisoned conditions in media of decreasing relative osmolality. Muscles were
incubated nonisometrically in hypotonic Krebs-Ringer buffers (Δ), isometrically in hypotonic Krebs-Ringer buffers (o),
and isometrically in hypotonic sodium pyrophosphate buffers (D).
b. Lactate dehydrogenase permeability of skeletal muscle under nonpoisoned conditions in media of decreasing relative
osmolality. Muscles were incubated nonisometrically in hypotonic Krebs-Ringer buffers (Δ), isometrically in hypotonic
Krebs-Ringer buffers (o), and isometrically in hypotonic sodium pyrophosphate buffers (D). The permeabilities were
calculated for an incubation interval of 60 min between the 30th and 90th min.
After 30 min of preincubation, the medium was replaced by fresh buffer of identical composition;
from 1. c. (47), modified.
Tab. 3. Lipid composition following incubation of hepatocyte
membranes in the presence or absence of calcium.
Constituent Percent of total lipid
weight
(mean + SEM)
Cholesterol
Cholesterol esters
Trigjycerides
Fatty acids
Lecithin
Lysolecithin
Sphingomyelin
Phosphatidyletha>
nolamine
no Ca2+
21.2 ± 1.8
17.8 ± 2.1
3.0 + 0.4
6.0 ± 0.4
20.9 + 3.1
3.4 ± 1.0
14.2 ± 1.3
13.6 + 1.0
4 mmol/1
Ca2+
19.6 + 1.6
14.9 ± 1.3
2.7 + 0.4
9.9 + 0.4
21.9 + 0.6
8.3 + 1.1
12.4 ± 1.3
10.4 ± 0.8
ns
ns
ns
< 0.001
ns
<0.01
ns
< 0.01
from 1. c. (56), modified
changes, however, also indicate indirect effects of
calcium through activation of the membrane-bound
phospholipases. The fonnation of more lysolecithin
would result rather in enhanced than impaired mem-
brane fluidity.
Probably, it is the alternation of rigid and labilized
parts of the membrane, which leads to local weaken^
ing of the structures. Together with the effect on the
cytoskeleton, p rtly cross-linkage, partly depolymer-
ization, the end result is the blebbing process (15,
47).
Figure 13 shows that modifications of the intracellu-
lar concentration of Ca2+ are not mandatory. Infu-
sion of low dose of phospholipase C (0.1 U/l) provo-
kes abrupt leakage of creatine kinase from the iso-
lated septum of rabbit heart without increase in cal-
cium or barium uptake (57). The 40-fold dose of
phospholipase C, however, leads to a massive release
of constitutive enzymes, and probably to irreversible
necrosis.
Since Judah and his co-workers (1956) published their
Undings on the accumulation of calcium in damaged
liver cells, shown on figure 14 (58), it has been gen-
erally understood that impaired intracellular calcium
homoeostasis plays a role in the loss of enzymes from
the cells. Whether it is generally the cause of increased
enzyme leakage, or just an early event, concomitant
with the release of cytosolic enzymes (48, 59 — 61), or
whether calcium accumulation is the ultimate com-
mpn result of all types of cell injury, are matters of
controversy. Evidently, the answer depends on the
species and age, of the organ studied, on the type
and severity of the cell damage and on the enzymes
in question (57, 59, 62).
For a long time, most investigators favoured the last
explanation. Thus, 20 years ago we too designed a
rather primitive graph (flg. 15) of the sequence of
events thought to be related to enzyme release during
J. Clin. Chem. Clin. Biochem. / Vol. 25,1987 / No. 9
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Fig. 13. Effect of phospholipase C (100 U/l) Infusion Q i)
on tissue 47Ca2+ uptake (upper panel), tissue I33Ba2+
uptake (middle panel), and the rate of creatine kinase
release (lower panel) in the adult rabbit heart septum;
from 1. c. (57), modified.
4 6 48
t [h]
Fig. 14. Intracellular calcium accumulation (o —o) and oxygen
consumption (o o) of rat liver in acute thioacet-
amide intoxication;
from L c. (58), modified.
cellular injury, which attempts to summarize the re-
sults of several groups working in the fifties and
sixties (26, 58, 63).
Recently more evidence has appeared in favour of
the importance of early calcium effects, particularly
in muscle cells.
A primary direct causative role may be ascribed to
calcium imbalance only under the extremely artificial
conditions that provoke the calcium paradox. How*
ever, it appeared sensible to Update the old scheme
in figure 15. This has been done in figure 16, which"
1,25 p
Fig. 15. Hypothetical scheme of the course of cell damage in
relation to enzyme release t;
from 1. c. (26), modified.
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Fig. 16. Hypothetical scheme of the course of cell damage in
relation to enzyme release II.
is likewise grossly simplified, but illustrates an at-
tempt to reconcile contradictory findings and points
of view by taking into considerätion the compartmen-
tation of the intracellular calcium, and by distitiguisli-
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ing a compensated and a decompensated disturbance
of the calcium equilibrium in the cytosol. Cytosolic
calcium homeostasis is regulated by the mitochondria
in dependence on NADPH, and by the endoplasmic
reticulum in dependence on GSH. Between 0.1 and
0.5 / , cytosolic calcium is controlled by the
plasma membrane permeability barrier against the
steep concentration gradient from the extracetlular
space.
Minor increases in membrane permeability, e.g. by
direct effects of bacterial exotoxins or phalloidin,
or by efflux of calcium from the cisternae of the
endoplasmic reticulum, e. g. due to lack of GSH after
its consumption for the detoxification of reactive
metabolites (60), lead to slight but fast elevations of
cytosolic Ca2+, which are sufficient to exert signal
effects like the activation of phospholipases and pro-
teases or structural modifications of the cytoskeleton
(15, 47, 53, 54). These intensify or even initiate the
membrane disorders, and cytosolic enzymes are lost
by leakage. This process is reversible (56), either by
blebbing, or by restoration of homoeostasis in the
presence of cytosolic ATP by means of the ion pumps,
or by the much more "risky" process of augmented
Sequestration of non-ionized calcium in the mito-
chondria. The latter process utilizes ATP and is satur-
able, and its failure and exhaustion indicates the point
of no return. While mitochondrial enzymes begin to
leak out, the cell dies — füll of calcium.
The scheme in figure 16 is not comprehensive.
Numerous important, possibly decisive points are
missing and those indicated are in part purely hypo-
thetical. In view of the sometimes confusing clinical
observations, much remains to be learned about en-
zyme release.
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